University of Münster
CRIS@UM
DE | EN

Dr. Vilmos Posevitz

No current affiliations available for this person. The person is no longer active at the university.

Publications

B7-H1 Selectively Controls T(H)17 Differentiation and Central Nervous System Autoimmunity via a Novel Non-PD-1-Mediated Pathway
Herold M, Posevitz V, Chudyka D, Hucke S, Gross C, Kurth F, Leder C, Loser K, Kurts C, Knolle P, Klotz L, Wiendl H (2015)
In: The Journal of Immunology, 195(8), 3584-3595. doi:10.4049/jimmunol.1402746
Research article (journal) | Peer reviewed | Published
Teriflunomide: A Proposed Mechanism of Action in Patients with Relapsing Multiple Sclerosis
Kieseier B, Posevitz V, Klotz L, Kaplan J, Wiendl H (2014)
In: Multiple Sclerosis, 20(7).
Research article (journal) | Peer reviewed | Published
B7-H1 limits T-cell-mediated brain endothelial cell dysfunction and endothelial barrier disruption in a spontaneous model of CNS autoimmunity
Kuzmanov I, Posevitz V, Hucke S, Chudyka D, Klotz L, Wiendl H (2014)
In: Multiple Sclerosis, 20(1).
Research article (journal) | Peer reviewed | Published
Affinity-dependent effects of Teriflunomide and impact on T cell metabolism
Eschborn M, Lindner M, Posevitz V, Zehn D, Wiendl H, Klotz L (2014)
In: Journal of Neuroimmunology, 275(1-2, SI), 59-60. doi:10.1016/j.jneuroim.2014.08.156
Research article (journal) | Peer reviewed | Published
L-Selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients.
Schwab N, Schneider-Hohendorf T, Posevitz V, Breuer J, Göbel K, Windhagen S, Brochet B, Vermersch P, Lebrun-Frenay C, Posevitz-Fejfár A, Capra R, Imberti L, Straeten V, Haas J, Wildemann B, Havla J, Kümpfel T, Meinl I, Niessen K, Goelz S, Kleinschnitz C, Warnke C, Buck D, Gold R, Kieseier BC, Meuth SG, Foley J, Chan A, Brassat D, Wiendl H (2013)
In: Neurology, 2013. doi:10.1212/WNL.0b013e3182a351fb
Research article (journal) | Peer reviewed | Published
Show all publications (7)